Correlation Between ALK Abell and Zealand Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ALK Abell and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ALK Abell and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ALK Abell AS and Zealand Pharma AS, you can compare the effects of market volatilities on ALK Abell and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ALK Abell with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ALK Abell and Zealand Pharma.

Diversification Opportunities for ALK Abell and Zealand Pharma

0.44
  Correlation Coefficient

Very weak diversification

The 3 months correlation between ALK and Zealand is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding ALK Abell AS and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and ALK Abell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ALK Abell AS are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of ALK Abell i.e., ALK Abell and Zealand Pharma go up and down completely randomly.

Pair Corralation between ALK Abell and Zealand Pharma

Assuming the 90 days trading horizon ALK Abell AS is expected to under-perform the Zealand Pharma. But the stock apears to be less risky and, when comparing its historical volatility, ALK Abell AS is 1.29 times less risky than Zealand Pharma. The stock trades about -0.05 of its potential returns per unit of risk. The Zealand Pharma AS is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  81,550  in Zealand Pharma AS on November 1, 2024 and sell it today you would lose (8,750) from holding Zealand Pharma AS or give up 10.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

ALK Abell AS  vs.  Zealand Pharma AS

 Performance 
       Timeline  
ALK Abell AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ALK Abell AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, ALK Abell is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Zealand Pharma AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zealand Pharma AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

ALK Abell and Zealand Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ALK Abell and Zealand Pharma

The main advantage of trading using opposite ALK Abell and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ALK Abell position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.
The idea behind ALK Abell AS and Zealand Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world